Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer

Breast cancer is characterized by a high incidence rate and its treatment challenges, particularly in certain subtypes. Consequently, there is an urgent need for the development of novel therapeutic approaches. Immunotherapy utilizing immune checkpoint inhibitors (ICIs) is currently gaining momentum...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hongsheng Zhang, Jintao Mi, Qi Xin, Weiwei Cao, Chunjiao Song, Naidan Zhang, Chengliang Yuan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-10-01
Edice:	Frontiers in Oncology
Témata:	CTLA-4 breast cancer immunotherapy immune checkpoint inhibitors clinical trials
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1256360/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!